http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3930741-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f4d86235703b3e2a1cb10b98722d80d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-062
filingDate 2020-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0274f348853b716a2bdfc5b095ae0e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb60ebf1dc09c2e2364b76fb5ac33403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f3f4996840b8196fb06f244131f638b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f48bf48a18494304046910f33c13274d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cadf1b83ceef560f3e18b8ed404d860f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e1a8b2c65cba12afeb6ed311d52dee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a939e19f21c8a317503275502ca3d316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b5a969701f3b1235c1406bcbe0cc655
publicationDate 2022-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3930741-A1
titleOfInvention Use of destruxin-type fungal cyclic peptides as antibacterial agents active against clostridium perfringens
abstract The invention relates to the use of a destruxin or derivatives thereof for preventing or combating Clostridium perfringens in human or veterinary therapy or in animal nutrition.
priorityDate 2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11077
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394040
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57473102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226438198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23676152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939

Total number of triples: 43.